Entering text into the input field will update the search result below

Tonix Pharma pops 8% on acquisition of R&D facility in Maryland

  • Tonix Pharmaceuticals Holding (NASDAQ:TNXP) jumps 8% premarket after signing a Purchase and Sale Agreement to acquire an ~48,000 square foot R&D facility in Frederick, MD to support its expanding infectious disease pipeline.
  • Tonix agreed to purchase the R&D facility from Southern Research. The

Recommended For You

More Trending News

About TNXP Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
TNXP--
Tonix Pharmaceuticals Holding Corp.